Xarelto Lawsuit Claims Drug Caused Hemorrhagic Pericardial Effusion

March 30, 2016 – – BloodThinnerHelp.com reports on an Arizona lawsuit that alleges the blood-thinning drug, Xarelto, caused a woman to suffer a life-threatening hemorrhagic pericardial effusion, a medical condition in which blood fills the sac around the heart and gets in the way of normal heart contractions. The woman who filed case number 2:16-cv-01359 claimed that she took Xarelto for less than two weeks and that she was diagnosed in 2014 with hemorrhagic pericardial effusion, pericardial tamponade and pleural effusion. In addition to claims that Xarelto was the reason for this diagnosis, the case further claims that Bayer AG and Johnson & Johnson withheld information about the lack of antidote, when the drug was released to the market, to reverse the drug’s blood-thinning effects.

This case is the latest of several thousand suits claiming that her bleeding complications resulted from use of the drug. Since December 2014 Xarelto lawsuits have been consolidated in New Orleans, Louisiana as part of a multidistrict litigation panel before U.S. District Judge Eldon Fallon. Judge Fallon has issued a “bellwether”program for the cases, through which early trial dates for the suits are expected to be scheduled for May and February of 2017. Those suits filed in Pennsylvania state court have been consolidated into a mass tort program for more efficient management.

Xarelto was approved by the FDA in 2011 for preventing blood clots and deep vein thrombosis in patients undergoing knee and hip replacements, as well as for atrial fibrillation, reducing the recurrence of blood clots and stent thrombosis. A phase III study of the use of Xarelto showed that 73% of participants in the study suffered from adverse side effects including internal bleeding or anemia. Commonly reported injuries include heart attacks, stroke, internal bleeding gastrointestinal bleeding, brain hemorrhages,rectal bleeding, pulmonary embolisms (blood clots in the lung), epidural hematoma.

As litigation is expected to continue, Attorney Joseph Osborne is currently working with patients who have taken Xarelto and may have suffered serious health complications alleged to be associated with the drug. Those who have suffered from complications have the opportunity to evaluate their legal rights and may be entitled to substantial compensation. Osborne is currently offering free consultations for those affected.

To request more information on Xarelto bleeding lawsuits, or to ask questions, please contact Joseph Osborne, Esq. by calling (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Joseph Osborne
866-425-8902
Mizner Park
433 Plaza Real Blvd., Ste. 271
Boca Raton, FL 33432

ReleaseID: 60008959